Encompass Health (NYSE:EHC – Get Rating) had its target price decreased by Stephens from $78.00 to $74.00 in a report released on Tuesday morning, The Fly reports. Stephens currently has an overweight rating on the stock.
Other equities research analysts have also issued research reports about the stock. Royal Bank of Canada decreased their target price on shares of Encompass Health from $85.00 to $82.00 in a research note on Wednesday, June 8th. StockNews.com lowered shares of Encompass Health from a buy rating to a hold rating in a research note on Friday, June 10th. TheStreet raised shares of Encompass Health from a c+ rating to a b- rating in a research note on Tuesday, March 15th. Raymond James reduced their price objective on shares of Encompass Health from $85.00 to $70.00 in a research note on Friday, June 17th. Finally, Credit Suisse Group reduced their price objective on shares of Encompass Health from $83.00 to $82.00 and set an outperform rating for the company in a research note on Friday, June 10th. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Encompass Health has an average rating of Buy and a consensus target price of $79.56.
Shares of NYSE:EHC opened at $54.72 on Tuesday. The firm has a fifty day moving average of $63.87 and a two-hundred day moving average of $65.26. The firm has a market capitalization of $5.46 billion, a P/E ratio of 13.99, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. Encompass Health has a 12-month low of $53.03 and a 12-month high of $85.75. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.32.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 20th. Stockholders of record on Wednesday, July 13th will be issued a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, July 12th. This represents a $1.12 annualized dividend and a dividend yield of 2.05%. Encompass Health’s payout ratio is 28.64%.
In related news, Director Kevin J. O’connor acquired 1,000 shares of the company’s stock in a transaction dated Friday, May 6th. The shares were bought at an average price of $66.48 per share, for a total transaction of $66,480.00. Following the acquisition, the director now owns 3,436 shares in the company, valued at approximately $228,425.28. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 2.70% of the company’s stock.
Several large investors have recently bought and sold shares of the company. Bank of America Corp DE increased its holdings in shares of Encompass Health by 1.5% during the 1st quarter. Bank of America Corp DE now owns 251,111 shares of the company’s stock worth $17,856,000 after purchasing an additional 3,660 shares during the period. Neuberger Berman Group LLC increased its stake in Encompass Health by 2.2% in the first quarter. Neuberger Berman Group LLC now owns 14,167 shares of the company’s stock valued at $1,007,000 after acquiring an additional 306 shares during the period. Capital Research Global Investors increased its stake in Encompass Health by 22.2% in the first quarter. Capital Research Global Investors now owns 638,583 shares of the company’s stock valued at $45,410,000 after acquiring an additional 116,183 shares during the period. Mirabella Financial Services LLP bought a new stake in Encompass Health in the first quarter valued at about $2,486,000. Finally, Eaton Vance Management increased its stake in Encompass Health by 46.9% in the first quarter. Eaton Vance Management now owns 118,191 shares of the company’s stock valued at $8,405,000 after acquiring an additional 37,739 shares during the period. Institutional investors own 91.70% of the company’s stock.
Encompass Health Company Profile (Get Rating)
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Zai Lab Stock Has Fallen to Value Levels
- Are These Cheap Copper Stocks Right For Your Portfolio?
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.